Dyne-101
- Generic Name
- Dyne-101
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
- First Posted Date
- 2022-08-01
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Dyne Therapeutics
- Target Recruit Count
- 72
- Registration Number
- NCT05481879
- Locations
- 🇫🇷
Institut de Myologie, Paris, France
🇩🇪Ludwig Maximilians University, Munich - Friedrich Baur Institut, Munich, Germany
🇮🇹Centro Clinico Nemo, Milan, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath